Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA.
Wu L, Ingle T, Liu Z, Zhao-Wong A, Harris S, Thakkar S, Zhou G, Yang J, Xu J, Mehta D, Ge W, Tong W, Fang H.
Wu L, et al. Among authors: xu j.
BMC Bioinformatics. 2019 Mar 14;20(Suppl 2):97. doi: 10.1186/s12859-019-2628-5.
BMC Bioinformatics. 2019.
PMID: 30871458
Free PMC article.